{"id":"https://openalex.org/W2973229339","doi":"https://doi.org/10.1002/pros.23899","title":"Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration\u2010resistant prostate cancer","display_name":"Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration\u2010resistant prostate cancer","publication_year":2019,"publication_date":"2019-09-09","ids":{"openalex":"https://openalex.org/W2973229339","doi":"https://doi.org/10.1002/pros.23899","mag":"2973229339","pmid":"https://pubmed.ncbi.nlm.nih.gov/31497882"},"language":"en","primary_location":{"id":"doi:10.1002/pros.23899","doi":"https://doi.org/10.1002/pros.23899","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pros.23899","pdf_url":null,"source":{"id":"https://openalex.org/S197000376","display_name":"The Prostate","issn_l":"0270-4137","issn":["0270-4137","1097-0045"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Prostate","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020223699","display_name":"Daniel J. George","orcid":"https://orcid.org/0000-0003-1499-7203","observed_orcids":["https://orcid.org/0000-0003-1499-7203","https://orcid.org/0000-0002-0836-8542"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniel J. George","raw_affiliation_strings":["Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina","Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053535513","display_name":"Susan Halabi","orcid":"https://orcid.org/0000-0003-4135-2777","observed_orcids":["https://orcid.org/0000-0003-4135-2777"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Halabi","raw_affiliation_strings":["Department of Biostatistics, Duke University, Durham, North Carolina","Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317"]},{"raw_affiliation_string":"Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061888417","display_name":"Patrick N Healy","orcid":"https://orcid.org/0000-0003-4520-2434","observed_orcids":["https://orcid.org/0000-0003-4520-2434"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Healy","raw_affiliation_strings":["Department of Biostatistics, Duke University, Durham, North Carolina","Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317"]},{"raw_affiliation_string":"Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043348550","display_name":"Ian Barak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ian Barak","raw_affiliation_strings":["Department of Biostatistics, Duke University, Durham, North Carolina","Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317"]},{"raw_affiliation_string":"Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013457105","display_name":"Carolyn Winters","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carolyn Winters","raw_affiliation_strings":["Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033835226","display_name":"Monika Anand","orcid":"https://orcid.org/0000-0001-8634-4952","observed_orcids":["https://orcid.org/0000-0001-8634-4952"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monika Anand","raw_affiliation_strings":["Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina"],"raw_orcid":"https://orcid.org/0000-0001-8634-4952","affiliations":[{"raw_affiliation_string":"Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073199126","display_name":"Rhonda Wilder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rhonda Wilder","raw_affiliation_strings":["Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Melissa Klein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Klein","raw_affiliation_strings":["Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056262199","display_name":"Elia Martinez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elia Martinez","raw_affiliation_strings":["Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044586794","display_name":"Andrew B. Nixon","orcid":"https://orcid.org/0000-0003-3971-2964","observed_orcids":["https://orcid.org/0000-0003-3971-2964"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew B. Nixon","raw_affiliation_strings":["Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina","Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000997350","display_name":"Michael Roger Harrison","orcid":"https://orcid.org/0000-0003-3776-8892","observed_orcids":["https://orcid.org/0000-0003-3776-8892"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael R. Harrison","raw_affiliation_strings":["Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina","Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078252133","display_name":"Russell Zelig Szmulewitz","orcid":"https://orcid.org/0000-0002-1444-3617","observed_orcids":["https://orcid.org/0000-0002-1444-3617"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Russell Szmulewitz","raw_affiliation_strings":["Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038489185","display_name":"Andrew J. Armstrong","orcid":"https://orcid.org/0000-0001-7012-1754","observed_orcids":["https://orcid.org/0000-0001-7012-1754"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew J. Armstrong","raw_affiliation_strings":["Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina","Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Medicine, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4390039326"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5020223699"],"corresponding_institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298","https://openalex.org/I4390039326"],"apc_list":{"value":3550,"currency":"USD","value_usd":3550},"apc_paid":null,"fwci":0.1836,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.57277512,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"79","issue":"15","first_page":"1752","last_page":"1761"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9959999918937683},{"id":"https://openalex.org/keywords/prednisone","display_name":"prednisone","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pazopanib","display_name":"pazopanib","score":1.0},{"id":"https://openalex.org/keywords/vegfr-tyrosine-kinase-inhibitors","display_name":"VEGFR inhibitors","score":0.8769999742507935},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.777999997138977},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8009999990463257},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9089999794960022},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8309999704360962},{"id":"https://openalex.org/keywords/pegfilgrastim","display_name":"pegfilgrastim","score":0.8330000042915344},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.8289999961853027},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8029999732971191},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9810000061988831},{"id":"https://openalex.org/keywords/plasma-vegf-levels","display_name":"plasma VEGF levels","score":0.753000020980835}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.8487569093704224},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8199455738067627},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7196095585823059},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.6949621438980103},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6536752581596375},{"id":"https://openalex.org/C2778439243","wikidata":"https://www.wikidata.org/wiki/Q7157043","display_name":"Pazopanib","level":4,"score":0.6150715947151184},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6084270477294922},{"id":"https://openalex.org/C2779256933","wikidata":"https://www.wikidata.org/wiki/Q58929","display_name":"Castration","level":3,"score":0.5806328058242798},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.48562899231910706},{"id":"https://openalex.org/C2781440318","wikidata":"https://www.wikidata.org/wiki/Q1806228","display_name":"Orchiectomy","level":2,"score":0.4378516674041748},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4113002121448517},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.15958833694458008},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.08738425374031067}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000077982","descriptor_name":"Progression-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/pros.23899","doi":"https://doi.org/10.1002/pros.23899","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pros.23899","pdf_url":null,"source":{"id":"https://openalex.org/S197000376","display_name":"The Prostate","issn_l":"0270-4137","issn":["0270-4137","1097-0045"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Prostate","raw_type":"journal-article"},{"id":"pmid:31497882","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31497882","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Prostate","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306078","display_name":"U.S. Department of Defense","ror":"https://ror.org/0447fe631"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W1545484184","https://openalex.org/W1945293306","https://openalex.org/W1963765725","https://openalex.org/W1972671221","https://openalex.org/W1972912578","https://openalex.org/W1985335252","https://openalex.org/W1991355732","https://openalex.org/W2004973733","https://openalex.org/W2012853695","https://openalex.org/W2015556765","https://openalex.org/W2019607817","https://openalex.org/W2028511648","https://openalex.org/W2055346449","https://openalex.org/W2070428637","https://openalex.org/W2073100248","https://openalex.org/W2080206213","https://openalex.org/W2080439368","https://openalex.org/W2085285915","https://openalex.org/W2095771928","https://openalex.org/W2100128029","https://openalex.org/W2100471642","https://openalex.org/W2101776780","https://openalex.org/W2116949558","https://openalex.org/W2117783793","https://openalex.org/W2120292596","https://openalex.org/W2127988517","https://openalex.org/W2149456801","https://openalex.org/W2156754474","https://openalex.org/W2157769714","https://openalex.org/W2159445058","https://openalex.org/W2159771669","https://openalex.org/W2160916229","https://openalex.org/W2161306413","https://openalex.org/W2162424705","https://openalex.org/W2165088640","https://openalex.org/W2166918329","https://openalex.org/W2167331614","https://openalex.org/W2216326174","https://openalex.org/W2296253991","https://openalex.org/W2405028681","https://openalex.org/W2409193283","https://openalex.org/W2409482913","https://openalex.org/W2431653148","https://openalex.org/W2488437679","https://openalex.org/W2553579606","https://openalex.org/W2858223152","https://openalex.org/W2921497169"],"related_works":["https://openalex.org/W2465759545","https://openalex.org/W2947924818","https://openalex.org/W2165088640","https://openalex.org/W1545272734","https://openalex.org/W3088858550","https://openalex.org/W4234056003","https://openalex.org/W2227075123","https://openalex.org/W2159445058","https://openalex.org/W2245153926","https://openalex.org/W2023288243"],"abstract_inverted_index":{"BACKGROUND:":[0],"Docetaxel":[1],"prednisone":[2,39,132],"is":[3,54],"a":[4,25,55,96,102,153,220],"standard":[5],"of":[6,37,60,68,95,155,203,229],"care":[7],"for":[8,47,152,234],"men":[9,84],"with":[10,40,85,225],"metastatic":[11],"castration-resistant":[12],"prostate":[13,115],"cancer":[14],"(mCRPC),":[15],"and":[16,49,71,75,80,92,104,111,122,124,136,163,188,190,198,206,215],"plasma":[17,125],"vascular":[18],"endothelial":[19],"growth":[20],"factor":[21,28],"(VEGF)":[22],"levels":[23],"are":[24],"poor":[26,222],"prognostic":[27],"in":[29,83,219],"this":[30,149,241],"population;":[31],"therefore,":[32],"we":[33],"evaluated":[34],"the":[35,93],"combination":[36,202],"docetaxel":[38],"pazopanib,":[41],"an":[42],"oral":[43],"VEGF":[44],"receptor":[45],"inhibitor,":[46],"safety":[48,91],"preliminary":[50],"efficacy.":[51],"METHODS:":[52],"This":[53],"two-site":[56],"phase":[57],"1b":[58],"Department":[59],"Defense":[61],"Prostate":[62],"Cancer":[63],"Clinical":[64],"Trials":[65],"Consortium":[66],"trial":[67],"docetaxel,":[69,204],"prednisone,":[70,205],"pazopanib":[72,137,207],"once":[73],"daily":[74,140],"ongoing":[76],"androgen":[77],"deprivation":[78],"therapy":[79],"prophylactic":[81],"pegfilgrastim":[82],"mCRPC.":[86,226],"The":[87,172,201],"primary":[88],"endpoint":[89],"was":[90,141,176,180,192,210],"determination":[94],"maximum":[97],"tolerated":[98],"dose":[99,150],"(MTD)":[100],"through":[101],"dose-escalation":[103],"expansion":[105],"design;":[106],"secondary":[107],"endpoints":[108],"included":[109,160],"progression-free":[110],"overall":[112],"survival":[113],"(OS),":[114],"specific":[116],"antigen":[117],"(PSA)":[118],"declines,":[119],"radiographic":[120],"responses,":[121],"pharmacokinetic":[123],"angiokine":[126],"biomarker":[127],"analyses.":[128],"RESULTS:":[129],"q3":[130],"weeks;":[131],"10":[133],"mg":[134,139],"daily;":[135],"800":[138],"reached.":[142],"Eleven":[143],"additional":[144],"patients":[145,224,235],"were":[146],"accrued":[147],"at":[148,212],"level":[151],"total":[154],"36":[156],"patients.":[157],"Dose-limiting":[158],"toxicities":[159],"neutropenia,":[161],"syncope,":[162],"hypertension.":[164],"Three":[165],"deaths":[166],"attributed":[167],"to":[168],"study":[169],"treatment":[170],"occurred.":[171],"objective":[173],"response":[174],"rate":[175],"31%;":[177],"median":[178],"PFS":[179],"14.1":[181],"months":[182,194],"(95%":[183,195],"confidence":[184],"interval":[185],"[CI]:":[186],"7.1":[187],"22.2);":[189],"OS":[191],"18.6":[193],"CI:":[196],"11.8":[197],"22.2).":[199],"CONCLUSIONS:":[200],"(with":[208],"pegfilgrastim)":[209],"tolerable":[211],"full":[213],"doses":[214],"demonstrated":[216],"promising":[217],"efficacy":[218],"relatively":[221],"risk":[223],"Further":[227],"development":[228],"predictive":[230],"biomarkers":[231],"may":[232],"enrich":[233],"who":[236],"receive":[237],"clinical":[238],"benefit":[239],"from":[240],"regimen.":[242]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-09-19T00:00:00"}